What is LipoCoat?
LipoCoat is a pioneering Dutch biotechnology firm focused on developing bio-inspired coatings that significantly enhance the safety, comfort, and performance of medical devices. Their proprietary technology replicates the natural phospholipid bilayer of cell membranes, imparting crucial properties such as anti-fouling, enhanced hydrophilicity, and non-thrombogenicity. This innovative approach positions LipoCoat at the forefront of surface solutions within the medical device and drug discovery sectors, with ongoing discovery and (pre-)clinical programs aimed at leading the market. The company's commitment to innovation has been recognized through over 20 awards, including 'European Biotech Startup of 2019' and 'Best Medical Device Coatings Company of 2020'.
How much funding has LipoCoat raised?
LipoCoat has raised a total of $1.6M across 1 funding round:
Other Financing Round
$1.6M
Other Financing Round (2020): $1.6M with participation from Enschede and Rabo Investments
Key Investors in LipoCoat
Enschede
Enschede is an entity that participated in the funding round. Further details on their investment focus are not publicly available.
Rabo Investments
Rabo Investments is the investment arm of Rabobank, dedicated to supporting companies in the Food & Agri and Sustainability sectors. They provide equity capital to transformative companies, leveraging their global network and industry expertise to foster resilient businesses.
What's next for LipoCoat?
With the recent infusion of major strategic capital, LipoCoat is poised for accelerated growth and expansion. The enterprise-level funding suggests a mature stage of development, likely enabling the company to scale its manufacturing capabilities, broaden its clinical trial scope, and solidify its market presence. This investment will be instrumental in translating LipoCoat's award-winning technology into widespread clinical application, potentially transforming patient care and medical device efficacy across various health and nutrition sectors. The company's strategic focus on bio-mimicry offers a compelling pathway to address unmet needs in biomaterials.
See full LipoCoat company page
